Studies have shown immediate-release opioids can be used supplementally when transdermal buprenorphine is being used to manage moderate-to-severe chronic pain.
The study cleared up confusion as whether or not immediate-release opioids would properly function with buprenorphine, which may displace or prevent competing mu-opioid agonists from binding.
More Articles on Anesthesia:
Drug EXPAREL Reduces Pain, Adverse Opioid Side Effects
Donald Bell Elected to Chair Tennessee Board of Nursing
Dr. Andrew Greenfield Named Senior VP of Anesthesiology at Sheridan Healthcare
